41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Isolated metastases of hepatocellular carcinoma in the right atrium: Case report and review of the literature

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to clarify the clinical features of patients with isolated HCC metastases to the heart. A 66-year-old female hospitalized with a hepatocellular carcinoma (HCC) ranging from the right to the left lobe and with a tumor thrombus in the main portal vein, was treated with intraarterial cisplatin, 5-fluouracil, adriamycin and mitomycin. Computed tomography (CT) one month later revealed that the HCC had progressed with multiple lung metastases and moderate ascites. The patient had no symptoms. Magnetic resonance imaging (MRI) and echocardiography revealed a round, movable tumor with a diameter of 2 cm in the right atrium (RA). The patient succumbed to HCC five months later. An autopsy revealed HCC with portal tumor thrombi and metastases to the lungs, inferior vena cava (IVC) and RA. The metastases in the RA and IVC were not continous with the intrahepatic tumor and were histologically attached to the endocardium and endothelium, respectively. An isolated metastasis of a HCC of the RA and IVC is extremely rare. In conclusion, although the majority of isolated metastases of HCC to the heart were diagnosed by echocardiography and were treated with mainly surgery, they had poor prognosis. The echocardiography should be performed for patients with advanced HCC. A novel treatment including molecular targeted drugs is required.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature.

          A 71-year-old man with hepatocellular carcinoma (HCC) presented with intracavitary cardiac involvement detected incidentally on surveillance computed tomography. Tumor with associated thrombus was found to extend from the liver through the inferior vena cava into the right atrium. This intracardiac mass prolapsed intermittently into the right ventricle, causing functional tricuspid stenosis. The mass was resected but recurred after 4 months, eventually causing refractory right-sided heart failure. This case illustrates how intracavitary cardiac involvement of HCC can develop insidiously and confer significant hemodynamic compromise. A review of the published research, including postmortem studies, demonstrates that the frequency of intracardiac mass lesions in HCC is not insignificant. In conclusion, early detection and diagnosis may have increasing importance in the advent of new therapies for treating advanced HCC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Hepatocellular Carcinoma with Intra-Atrial Tumor Thrombi

            Background: In patients with advanced hepatocellular carcinoma (HCC), inferior vena cava/intra-right atrial (IVC/RA) tumor thrombi are not uncommon findings and are usually associated with extremely poor outcome. Surgical interventions as well as nonsurgical approaches, such as transcatheter arterial chemoembolization and radiotherapy, have been used in the treatment of patients with symptomatic IVC/RA tumor thrombi. However, such therapeutic modalities are usually not feasible when a patient shows poor general performance, the presence of metastatic disease, and underlying hepatic dysfunction. Such patients show limited survival. Material and Methods: Herein we describe 3 patients with advanced-stage HCC whose IVC/RA tumor thrombi and primary tumors regressed remarkably after low-dose thalidomide (200–400 mg/day) therapy. An Entrez PUBMED search of English Literature articles was performed to identify other cases of RA tumor thrombi in HCC who had received various treatments. Results: Two of our patients survived for more than 15 months after the diagnosis of IVC/RA tumor thrombi, while the other had effective symptomatic palliation associated with a drastic fall of AFP serum levels and significant tumor regression within 4 weeks of thalidomide therapy. A literature review suggested that the survival of our patients is comparable with that of occasional patients who had received aggressive surgical intervention. Conclusions: Our results suggest that, despite the low tumor response rate in earlier studies, thalidomide therapy may sometimes provide effective palliation for patients with far advanced HCC with symptomatic IVC/RA tumor thrombi and who are not candidates for alternative treatment options.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases.

              We studied the features of 18 cases of hepatocellular carcinoma (HCC) with prominent intra-atrial tumor growth that were seen among 439 autopsy cases of HCC. Diuretic-resistant, marked edema in the lower extremities and marked venous dilatation in the abdominal wall were observed in 14 cases (77.7%) and five cases (27.7%), respectively. Consistent tachycardia was seen in three cases. Macroscopically, most of the cases showed an infiltrative or mixed (infiltrative and nodular) growth pattern. A continuous tumor thrombus involving the right atrium, the IVC, and the hepatic vein was seen in 15 cases; a tumor that involved the right atrium alone was present in three cases. In five cases, the tumor bolus crossed the tricuspid valve and entered the ventricle.
                Bookmark

                Author and article information

                Journal
                Oncol Lett
                Oncol Lett
                OL
                Oncology Letters
                D.A. Spandidos
                1792-1074
                1792-1082
                May 2013
                08 March 2013
                08 March 2013
                : 5
                : 5
                : 1505-1508
                Affiliations
                [1 ]Department of Multidisciplinary Internal Medicine, Division of Medicine and Clinical Science, School of Medicine, Yonago 683-8504, Japan;
                [2 ]Division of Molecular Pathology, Tottori University, Yonago 683-8504, Japan
                Author notes
                Correspondence to: Dr Masahiko Koda, Department of Multidisciplinary Internal Medicine, Division of Medicine and Clinical Science, Tottori University School of Medicine, 36-1 Nishicho, Yonago 683-8504, Japan, E-mail: masakoda@ 123456grape.med.tottori-u.ac.jp
                Article
                ol-05-05-1505
                10.3892/ol.2013.1240
                3678705
                23760591
                cc945f50-a6db-4747-b303-d102095f98bc
                Copyright © 2013, Spandidos Publications

                This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

                History
                : 28 November 2012
                : 21 February 2013
                Categories
                Articles

                Oncology & Radiotherapy
                hepatocellular carcinoma,isolated atrial metastasis,prognosis
                Oncology & Radiotherapy
                hepatocellular carcinoma, isolated atrial metastasis, prognosis

                Comments

                Comment on this article